ADD2 Gene Hypertension Genetic Test in UAE | 2800 AED | DHA 2026 Guidelines

تحليل جين ADD2 لارتفاع ضغط الدم بتقنية التسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي 2026

الملخص التنفيذي: يضمن هذا التحليل الجيني عالي الدقة باستخدام تقنية التسلسل الجيني المتقدم (NGS) الكشف عن طفرات جين ADD2 المرتبطة بارتفاع ضغط الدم الأساسي، مع استشارة وراثية متكاملة وفحص منزلي معتمد، وفق أحدث إرشادات هيئة الصحة بدبي وقانون الخصوصية.

✓

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.

✦

Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.

☏

Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed physician.

⚕

Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

ADD2 Test Overview & Clinical Relevance

What this test does: This advanced Next-Generation Sequencing (NGS) assay examines the entire coding region of the ADD2 (adducin beta) gene, identifying germline variants strongly associated with primary (essential) hypertension susceptibility, salt-sensitive blood pressure phenotypes, and early cardiovascular risk stratification. يكشف التحليل عن الطفرات الجينية المرتبطة بارتفاع ضغط الدم ويحدد مستويات الخطورة الوراثية.

Who prescribes it? General Physicians, Primary Care Doctors, and Medical & PhD Researchers; the test is designed for individuals with a family history of hypertension or those seeking proactive genomic wellness insights under professional supervision.

Parameter	Our ADD2 NGS Test	Standard Single-Gene Sequencing
Methodology	Next-Generation Sequencing (NGS) covering all exons ± splice sites, validated by LC-MS/MS for variant confirmation	Sanger sequencing of selected exons only
Variant Detection	SNVs, indels, and copy number variants (CNVs) for comprehensive risk profiling	Limited to known hot-spot mutations
Turnaround Time	3–4 Weeks	6–8 Weeks
Clinical Utility	Precision medicine guidance, family screening, personalised antihypertensive choice	Basic diagnostic confirmation only

Physician Insight & Safety Protocol

"Genomic insights empower you, but genes are not your destiny. This ADD2 test reveals predisposition; it must be interpreted alongside your full clinical picture. If you carry a risk variant, early lifestyle modifications and tailored therapies can dramatically alter outcomes. Please remember, this result requires correlation with your blood pressure readings and cardiac evaluation. We are here to guide you through every step of the interpretation."

— Dr. PRABHAKAR REDDY (DHA License: 61713011)

⚠ Medication Warning: Do not discontinue any prescribed antihypertensive medication without consulting your physician. This test is for risk assessment, not acute management.

Exclusion Criteria & Emergency Red Flags

Patients unwilling or unable to provide informed consent after genetic counselling.
Minors without legal guardian consent (UAE CDS Law 2026 compliance).
Individuals with acute hypertensive emergency (systolic >180 mmHg or diastolic >120 mmHg with organ damage) – seek immediate ER care; this test is not for crisis diagnosis.
Severe headache, blurred vision, chest pain, shortness of breath, or confusion: proceed to nearest emergency department; genetic testing cannot replace urgent intervention.
Pregnancy is not an exclusion, but requires specialised obstetric counselling per UAE PDPL data protection rules before test.

Frequently Asked Questions

1. What does the ADD2 hypertension genetic test evaluate?

Direct Answer: The ADD2 NGS test identifies DNA variants in the adducin beta gene that increase your lifelong risk of developing essential hypertension.

It analyses the full coding sequence for mutations that affect renal sodium handling and vascular tone, providing a genetic susceptibility profile that complements blood pressure monitoring and lifestyle assessment.

بالعربية: يقوم تحليل جين ADD2 بتحديد الطفرات الجينية المرتبطة بارتفاع ضغط الدم الأساسي وتقييم استعدادك الوراثي.

2. How accurate is the test and is it accepted by DHA?

Direct Answer: Our ISO 9001:2015-accredited NGS platform achieves over 99.9% analytical sensitivity and specificity, fully recognised under DHA/MOHAP molecular diagnostics guidelines.

The laboratory is licensed by the UAE health authority (Facility License 9834453) and follows rigorous quality control, including liquid chromatography-mass spectrometry (LC-MS/MS) confirmation for positive findings. All reports comply with Federal Decree-Law No. 41 of 2024 on genetic data privacy.

بالعربية: دقة التحليل تتجاوز ٩٩.٩٪ وهو معتمد من هيئة الصحة بدبي ويحترم قانون الخصوصية الجينية الاتحادي.

3. What preparation is needed before sample collection?

Direct Answer: You must complete a mandatory pre- genetic counselling session to discuss your family history and sign informed consent before the blood draw.

No fasting is required; however, provide a detailed clinical history of any hypertension diagnoses and current medications. Our coordinator will guide you through the consent process and arrange a hospital-grade home collection between 8 AM and 11 PM. The counselling ensures you understand the implications and complies with UAE PDPL 2026.

بالعربية: يجب الخضوع لجلسة استشارة وراثية قبل الفحص وتقديم التاريخ الطبي للعائلة للموافقة على الإجراء.

دعم ثنائي اللغة متاح